All-trans retinoic acid’s action against acute promyelocytic leukemia is probably related to promoting the transcriptional activation of genes related to the differentiation and regulation of autophagy through the inhibition of the mammalian target of rapamycin (mTOR) [130]. The gene discussed is MTOR; the disease is acute promyelocytic leukemia.